Update on the management of symptoms in schizophrenia: focus on amisulpride

@inproceedings{Mortimer2009UpdateOT,
  title={Update on the management of symptoms in schizophrenia: focus on amisulpride},
  author={Ann Margaret Mortimer},
  booktitle={Neuropsychiatric disease and treatment},
  year={2009}
}
Amisulpride is an atypical antipsychotic drug with a unique receptor pharmacology which is dose dependent. It is a standard treatment in dysthymia as well as in psychosis. Amisulpride is efficacious, effective and well tolerated in positive symptoms of schizophrenia: there is extensive evidence that it treats negative symptoms when given in low doses, although relative lack of EPS and an antidepressant effect may contribute. In first-episode patients amisulpride is an option, although there is… CONTINUE READING
7 Citations
139 References
Similar Papers

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 139 references

Effectiveness of antipsychotic drugs in first - episode schizophrenia and schizophreniform disorder : an open randomised clinical trial

  • R Kahn, W Fleischhaker, H Boter
  • Lancet
  • 2008

Effectiveness of antipsychotic drugs in firstepisode schizophrenia and schizophreniform disorder : an open randomised clinical trial

  • R Kahn, W Fleischhaker, H Boter
  • Lancet
  • 2008

Effects of amisulpride on the cognitive function of patients with schizophrenia who switched from risperidone

  • Wang Y-T, Chiu N-Y, Jou S-H
  • Int J Psychiatry Clini Pract
  • 2008
1 Excerpt

Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis

  • S Ruhmann, A Bechdolf, K Kuhn
  • Br J Psychiatry. 2007;191(suppl 51):s88–s95
  • 2007
1 Excerpt

Similar Papers

Loading similar papers…